Tyler Luyben

Tyler Luyben, PhD


Tyler joined Sixty Degree Capital in January of 2020.

Tyler has worked for Toronto healthcare startup Edesa Biotech Inc in business development, regulatory affairs, investor relations, and clinical operations roles. He has worked at the Lunenfeld-Tanenbaum Research Institute at Toronto’s Mount Sinai Hospital, working on a novel light-based treatment modality for Alzheimer’s disease and other memory disorders. Tyler holds a Ph.D. in Molecular Genetics from the University of Toronto and H.B.Sc in Genetics from Western University.